Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VIJAYAKRISHNA K GADI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1053358671
CMS profile
2511
Location
SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$134,900.60

100 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Stemline Therapeutics Inc. $50,652.71 37
Seagen Inc. $29,023.20 7
Puma Biotechnology, Inc. $23,008.72 26
Gilead Sciences, Inc. $14,679.26 13
AstraZeneca Pharmaceuticals LP $10,719.31 10
NOVARTIS PHARMACEUTICALS CORPORATION $3,150.00 1
Eli Lilly and Company $2,700.00 1
Hologic Sales and Service, LLC $919.60 3
Eisai Inc. $29.92 1
MorphoSys, US Inc. $17.88 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

100 matching records · $134,900.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 100 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 100.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Puma Biotechnology, Inc. $150.0912/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059048403 CMS
Stemline Therapeutics Inc. $232.1712/22/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041439 CMS
Stemline Therapeutics Inc. $7,410.0012/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041449 CMS
Seagen Inc. $11,880.0012/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772163 CMS
Seagen Inc. $204.0012/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772221 CMS
Seagen Inc. $58.8912/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772229 CMS
Seagen Inc. $660.0012/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772169 CMS
Stemline Therapeutics Inc. $419.6512/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041459 CMS
Stemline Therapeutics Inc. $375.1512/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041521 CMS
AstraZeneca Pharmaceuticals LP $2,740.0012/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261012027959 CMS
Stemline Therapeutics Inc. $120.0012/08/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041511 CMS
AstraZeneca Pharmaceuticals LP $2,055.0012/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015667877 CMS
Gilead Sciences, Inc. $19.4012/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025837747 CMS
Gilead Sciences, Inc. $19.6012/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025830781 CMS
Stemline Therapeutics Inc. $106.5712/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041541 CMS
AstraZeneca Pharmaceuticals LP $159.6812/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011607641 CMS
AstraZeneca Pharmaceuticals LP $421.5012/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016239605 CMS
Gilead Sciences, Inc. $120.1912/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025514771 CMS
Gilead Sciences, Inc. $18.8012/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025862482 CMS
Stemline Therapeutics Inc. $1,560.0012/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041399 CMS
Puma Biotechnology, Inc. $75.6011/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059059841 CMS
Seagen Inc. $11,880.0011/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772133 CMS
AstraZeneca Pharmaceuticals LP $52.2611/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015758581 CMS
AstraZeneca Pharmaceuticals LP $28.6211/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016172321 CMS
Stemline Therapeutics Inc. $1,560.0011/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041403 CMS
Stemline Therapeutics Inc. $379.9511/10/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041393 CMS
Stemline Therapeutics Inc. $401.1011/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041453 CMS
Stemline Therapeutics Inc. $28.0310/27/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041409 CMS
Stemline Therapeutics Inc. $2,340.0010/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041493 CMS
AstraZeneca Pharmaceuticals LP $3,767.5010/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014731853 CMS
Seagen Inc. $1,040.3110/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995772208 CMS
Gilead Sciences, Inc. $9,370.0010/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261035502369 CMS
Stemline Therapeutics Inc. $5,070.0009/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041505 CMS
Puma Biotechnology, Inc. $137.3309/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059048025 CMS
Puma Biotechnology, Inc. $319.8009/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059048429 CMS
Puma Biotechnology, Inc. $199.3409/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059048439 CMS
Puma Biotechnology, Inc. $171.8309/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059049121 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $3,150.0009/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993440943 CMS
Stemline Therapeutics Inc. $166.7509/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041531 CMS
Stemline Therapeutics Inc. $176.7509/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041525 CMS
Stemline Therapeutics Inc. $4,290.0009/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041413 CMS
Stemline Therapeutics Inc. $332.2109/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041515 CMS
Stemline Therapeutics Inc. $93.0309/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041501 CMS
AstraZeneca Pharmaceuticals LP $1,370.0009/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015033097 CMS
Eisai Inc. $29.9209/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023336455 CMS
AstraZeneca Pharmaceuticals LP $24.4109/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016252795 CMS
AstraZeneca Pharmaceuticals LP $100.3408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015249649 CMS
Stemline Therapeutics Inc. $9.3008/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041535 CMS
Stemline Therapeutics Inc. $5,850.0008/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041389 CMS
Hologic Sales and Service, LLC $631.6208/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261024883345 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $26,424.19 37
PY2020 $31,656.38 30
PY2021 $122,404.05 135
PY2022 $81,889.08 91
PY2023 $134,900.60 100
PY2024 $106,018.91 98
PY2025 $69,804.26 85

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
VIJAYAKRISHNA K GADI, NPI 1053358671. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1053358671.
APA 7
IndustryPayments. (2026). VIJAYAKRISHNA K GADI, NPI 1053358671 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1053358671
Bluebook
VIJAYAKRISHNA K GADI, NPI 1053358671, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1053358671.

Source: Centers for Medicare & Medicaid Services, Open Payments.